Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standar…
Dhanda A; Bodger K; Hood S; Henn C; Allison M; Amasiatu C; Burton R; Cramp M; Forrest E; Khetani M; MacGilchrist A; Masson S; Parker R; Sheron N; Simpson K; Vergis N; White M; BASL ARLD SIG National Service Evaluation Group.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oes…
Cho YK; Kim JH; Kim HS; Kim TO; Oh JH; Choi SC; Moon JS; Lee SK; Jung SW; Kim SS; Jung HK; Lee SP; Cheon GJ; Park MI; Jung HY; Ko KH; Sung IK; Lee SH; Lee JY; Lee ST; Rhee PL; Kim N; Hong SJ; Kim HJ; Kim GH; Lee KJ; Kim SK; Shin WG; Lee OY.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary chola…
de Veer RC; Harms MH; Corpechot C; Thorburn D; Invernizzi P; Janssen HLA; Battezzati PM; Nevens F; Lindor KD; Floreani A; Ponsioen CY; Mayo MJ; Parés A; Mason AL; Kowdley KV; Trivedi PJ; Hirschfield GM; Bruns T; Dalekos GN; Gatselis NK; Verhelst X; Lammers WJ; Hansen BE; van Buuren HR; van der Meer AJ; Global PBC Study Group.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disea…
Chanchlani N; Lin S; Auth MK; Lee CL; Robbins H; Looi S; Murugesan SV; Riley T; Preston C; Stephenson S; Cardozo W; Sonwalkar SA; Allah-Ditta M; Mansfield L; Durai D; Baker M; London I; London E; Gupta S; Di Mambro A; Murphy A; Gaynor E; Jones KDJ; Claridge A; Sebastian S; Ramachandran S; Selinger CP; Borg-Bartolo SP; Knight P; Sprakes MB; Burton J; Kane P; Lupton S; Fletcher A; Gaya DR; Colbert R; Seenan JP; MacDonald J; Lynch L; McLachlan I; Shields S; Hansen R; Gervais L; Jere M; Akhtar M; Black K; Henderson P; Russell RK; Lees CW; Derikx LAAP; Lockett M; Betteridge F; De Silva A; Hussenbux A; Beckly J; Bendall O; Hart JW; Thomas A; Hamilton B; Gordon C; Chee D; McDonald TJ; Nice R; Parkinson M; Gardner-Thorpe H; Butterworth JR; Javed A; Al-Shakhshir S; Yadagiri R; Maher S; Pollok RCG; Ng T; Appiahene P; Donovan F; Lok J; Chandy R; Jagdish R; Baig D; Mahmood Z; Marsh L; Moss A; Abdulgader A; Kitchin A; Walker GJ; George B; Lim YH; Gulliver J; Bloom S; Theaker H; Carlson S; Cummings JRF; Livingstone R; Beale A; Carter JO; Bell A; Coulter A; Snook J; Stone H; Kennedy NA; Goodhand JR; Ahmad T; IMSAT study investigators.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory …
Volkers A; Straatmijer T; Duijvestein M; Sales A; Levran A; van Schaik F; Maljaars J; Gecse K; Ponsioen C; Grootjans J; Hanzel J; Tack G; Jansen J; Hoentjen F; de Boer N; van der Marel S; Dijkstra G; Oldenburg B; Löwenberg M; van der Meulen A; D Haens G; IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Review article: Systemic consequences of coeliac disease.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of U…
Hawthorne AB; Glatter J; Blackwell J; Ainley R; Arnott I; Barrett KJ; Bell G; Brookes MJ; Fletcher M; Muhammed R; Nevill AM; Segal J; Selinger CP; St Clair Jones A; Younge L; IBD UK Board IBD UK Task & Finish Group; Lamb CA.
Aliment Pharmacol Ther
(Unknown)
Published: 2022